Procyon Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93M Sell
13,275
-822
-6% -$227K 0.13% 150
2026
Q1
$4.16M Sell
14,097
-421
-3% -$125K 0.2% 111
2025
Q4
$3.96M Sell
14,518
-289
-2% -$78.5K 0.2% 107
2025
Q3
$4M Sell
14,807
-2,405
-14% -$654K 0.24% 83
2025
Q2
$4.74M Sell
17,212
-1,517
-8% -$413K 0.44% 51
2025
Q1
$4.97M Buy
18,729
+777
+4% +$192K 0.3% 78
2024
Q4
$4.17M Sell
17,952
-2,607
-13% -$599K 0.26% 86
2024
Q3
$4.54M Sell
20,559
-1,334
-6% -$276K 0.31% 78
2024
Q2
$4.3M Buy
21,893
+1,452
+7% +$300K 0.32% 71
2024
Q1
$4.4M Sell
20,441
-522
-2% -$110K 0.34% 68
2023
Q4
$4.41M Buy
20,963
+4,679
+29% +$998K 0.38% 60
2023
Q3
$3.26M Sell
16,284
-1,061
-6% -$211K 0.33% 72
2023
Q2
$3.21M Buy
17,345
+3,008
+21% +$556K 0.4% 58
2023
Q1
$2.75M Buy
14,337
+4,348
+44% +$786K 0.46% 48
2022
Q4
$1.68M Buy
9,989
+4,490
+82% +$780K 0.31% 76
2022
Q3
$974K Buy
5,499
+889
+19% +$176K 0.24% 97
2022
Q2
$944K Buy
4,610
+517
+13% +$110K 0.21% 104
2022
Q1
$973K Buy
4,093
+759
+23% +$178K 0.2% 105
2021
Q4
$762K Buy
3,334
+1,506
+82% +$331K 0.16% 125
2021
Q3
$354K Buy
1,828
+142
+8% +$28.8K 0.09% 209
2021
Q2
$359K Buy
1,686
+384
+29% +$81.1K 0.1% 179
2021
Q1
$266K Buy
1,302
+203
+18% +$40K 0.12% 195
2020
Q4
$200K Buy
+1,099
New +$187K 0.1% 223
2020
Q3
Sell
-1,016
Closed -$165K 357
2020
Q2
$165K Sell
1,016
-181
-15% -$32.4K 0.09% 213
2020
Q1
$207K Sell
1,197
-1,603
-57% -$319K 0.14% 145
2019
Q4
$562K Buy
+2,800
New +$574K 0.34% 69

Other funds holding CME

Procyon Advisors's CME Position: Q2 2026 in Review

Procyon Advisors reduced its CME Group (CME) stake by 5.8% in Q2 2026, selling an estimated $227K and leaving 13,275 shares worth $2.93M. The position accounts for 0.13% of the portfolio, ranked #150.

Procyon Advisors first reported a position in CME in Q4 2019 and has held it in 26 quarters since. The position peaked at $4.97M in Q1 2025. 593 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Procyon Advisors held 13,275 shares of CME Group worth $2.93M as of Q2 2026.
  • Procyon Advisors sold 822 CME Group shares in Q2 2026, an estimated $227K.
  • CME Group made up 0.13% of Procyon Advisors's portfolio in Q2 2026, its #150 holding.
  • Procyon Advisors first reported a position in CME Group in Q4 2019 and has held it in 26 quarters since.
  • Procyon Advisors's CME Group position peaked at $4.97M in Q1 2025.
  • 593 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.